Incyte to Present at Upcoming Investor Conferences
Get Alerts INCY Hot Sheet
Join SI Premium – FREE
WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte Corporation (Nasdaq: INCY) announced today that it will present at the following investor conferences during the month of June:
- Jefferies 2016 Healthcare Conference on Wednesday, June 8, 2016 at 2:00 pm (EDT) in New York; and
- Goldman Sachs 37th Annual Global Healthcare Conference on Wednesday, June 8, 2016 at 2:00 pm (PDT) / 5:00 pm (EDT) in Rancho Palos Verdes
The presentations will be webcast live and can be accessed at www.incyte.com in the Investors section under “Events and Presentations”. Investors interested in listening to the live webcasts should log on before the start time in order to download any software required.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company's web site at www.incyte.com.
Follow @Incyte on Twitter at https://twitter.com/Incyte.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160518005013/en/
Incyte Corporation
Media
Catalina Loveman, +1
302-498-6171
[email protected]
or
Investors
Michael
Booth, DPhil, +1 302-498-5914
[email protected]
Source: Incyte Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Beyond the Credential: As AI Erases the 'Entry-Level Job' and Climate Volatility Accelerates, Planet Classroom Unveils July Lineup Mapping the New Rules of Human Resilience
- Honoring Independence Day and the Bright Future of American Innovation
- 5 Best Crypto Presales as Bitcoin Whales Buy $16.7B and Retail Looks for the Next Early Entry
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Goldman Sachs, Jefferies & Co, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share